Skip to main content
Earnings Labs
Structure Therapeutics Inc. logo

Structure Therapeutics Inc. (GPCR)

NASDAQ·Healthcare·Biotechnology

$49.69

+2.75%

Mkt Cap $3.25B

Analyst Ratings

Buy

3

Hold

0

Sell

0

Price Target (16 analysts)

$111.60

Range $70.00$145.00

Implied Upside

+124.6%

Consensus $111.60 vs current $49.69